Results 221 to 230 of about 183,149 (258)
Some of the next articles are maybe not open access.
The challenge of vaccine safety
Seminars in Pediatric Infectious Diseases, 2002Vaccines always will involve some risk, and risk always involves some public concern. Although the benefits of routine vaccination greatly outweigh any adverse effects, our consumer society seeks to eliminate all risk. The balance of risk and benefit appears to falter by the very success of preventing disease: in the immediate absence of the disease ...
Robert M, Jacobson +2 more
openaire +2 more sources
Current Opinion in Allergy & Clinical Immunology, 2012
To review recent publications on the safety of influenza vaccines [both the injectable, inactivated trivalent influenza vaccine (TIV) and the intranasal, live attenuated influenza vaccine (LAIV)] and new recommendations regarding their use.Numerous studies have demonstrated that TIV can be safely administered to patients with egg allergy.
openaire +2 more sources
To review recent publications on the safety of influenza vaccines [both the injectable, inactivated trivalent influenza vaccine (TIV) and the intranasal, live attenuated influenza vaccine (LAIV)] and new recommendations regarding their use.Numerous studies have demonstrated that TIV can be safely administered to patients with egg allergy.
openaire +2 more sources
Vaccine Safety Controversies and the Future of Vaccination Programs
The Pediatric Infectious Disease Journal, 2005In the years following the hepatitis B vaccination/multiple sclerosis controversy, a number of new issues regarding vaccine safety have been raised, in some cases leading to more debate and confusion. Against this background, an international group of experts was convened to review the current points of view concerning the use of thimerosal as a ...
François, Guido +9 more
openaire +3 more sources
2010
To proof the safety of a vaccine is much more challenging than proving its efficacy. Many vaccines are administered to several hundred million, often healthy people (e.g., childhood vaccines), in which case even extremely rare but serious adverse vaccine events can come to light, which may change the opinion of the medical community on the benefit/risk
openaire +1 more source
To proof the safety of a vaccine is much more challenging than proving its efficacy. Many vaccines are administered to several hundred million, often healthy people (e.g., childhood vaccines), in which case even extremely rare but serious adverse vaccine events can come to light, which may change the opinion of the medical community on the benefit/risk
openaire +1 more source
Journal de pharmacie de Belgique, 2002
The high standard of safety that is expected from vaccines can only be obtained if these products undergo in depth evaluation of their side effects before marketing authorization is guaranted, as well as post-marketing surveillance and investigation of reported adverse events. The evaluation of the benefit/risk balance of vaccines is a dynamic process,
openaire +2 more sources
The high standard of safety that is expected from vaccines can only be obtained if these products undergo in depth evaluation of their side effects before marketing authorization is guaranted, as well as post-marketing surveillance and investigation of reported adverse events. The evaluation of the benefit/risk balance of vaccines is a dynamic process,
openaire +2 more sources